| The mutational landscape of adenoid cystic carcinoma AS Ho, K Kannan, DM Roy, LGT Morris, I Ganly, N Katabi, D Ramaswami, ... Nature genetics 45 (7), 791-798, 2013 | 470 | 2013 |
| Circulating miR-210 as a novel hypoxia marker in pancreatic cancer AS Ho, X Huang, H Cao, C Christman-Skieller, K Bennewith, QT Le, ... Translational oncology 3 (2), 109-113, 2010 | 386 | 2010 |
| Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS) AS Ho, EE Sarti, KS Jain, H Wang, IJ Nixon, AR Shaha, JP Shah, ... Thyroid 24 (5), 832-839, 2014 | 353 | 2014 |
| Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS N Agrawal, Y Jiao, M Sausen, R Leary, C Bettegowda, NJ Roberts, ... The Journal of Clinical Endocrinology & Metabolism 98 (2), E364-E369, 2013 | 263 | 2013 |
| Metastatic lymph node burden and survival in oral cavity cancer AS Ho, S Kim, M Tighiouart, C Gudino, A Mita, KS Scher, A Laury, ... Journal of Clinical Oncology 35 (31), 3601, 2017 | 240 | 2017 |
| Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach D Gius, H Cui, CM Bradbury, J Cook, DDK Smart, S Zhao, L Young, ... Cancer cell 6 (4), 361-371, 2004 | 219 | 2004 |
| Decision making in the management of recurrent head and neck cancer AS Ho, DH Kraus, I Ganly, NY Lee, JP Shah, LGT Morris Head & neck 36 (1), 144-151, 2014 | 195 | 2014 |
| Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma AS Ho, A Ochoa, G Jayakumaran, A Zehir, CV Mayor, J Tepe, V Makarov, ... The Journal of clinical investigation 129 (10), 4276-4289, 2019 | 150 | 2019 |
| Wide inter-institutional variation in performance of a molecular classifier for indeterminate thyroid nodules JL Marti, V Avadhani, LA Donatelli, S Niyogi, B Wang, RJ Wong, ... Annals of surgical oncology 22, 3996-4001, 2015 | 140 | 2015 |
| Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence AS Ho, GJ Tsao, FW Chen, T Shen, MJ Kaplan, AD Colevas, NJ Fischbein, ... Cancer 119 (7), 1349-1356, 2013 | 129 | 2013 |
| Incidence of oropharyngeal cancer among elderly patients in the United States ZS Zumsteg, G Cook-Wiens, E Yoshida, SL Shiao, NY Lee, A Mita, C Jeon, ... JAMA oncology 2 (12), 1617-1623, 2016 | 126 | 2016 |
| Treatment at high‐volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer JM David, AS Ho, M Luu, EJ Yoshida, S Kim, AC Mita, KS Scher, SL Shiao, ... Cancer 123 (20), 3933-3942, 2017 | 123 | 2017 |
| Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation SE Mowry, A Ho, MM LoTempio, A Sadeghi, KE Blackwell, MB Wang The Laryngoscope 116 (9), 1589-1593, 2006 | 99 | 2006 |
| Pediatric tracheal stenosis AS Ho, PJ Koltai Otolaryngologic Clinics of North America 41 (5), 999-1021, 2008 | 97 | 2008 |
| Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer AS Ho, S Kim, M Tighiouart, C Gudino, A Mita, KS Scher, A Laury, ... JAMA oncology 4 (7), 985-989, 2018 | 96 | 2018 |
| Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates AS Ho, L Davies, IJ Nixon, FL Palmer, LY Wang, SG Patel, I Ganly, ... Cancer 121 (11), 1793-1799, 2015 | 95 | 2015 |
| Quantitative survival impact of composite treatment delays in head and neck cancer AS Ho, S Kim, M Tighiouart, A Mita, KS Scher, JB Epstein, A Laury, ... Cancer 124 (15), 3154-3162, 2018 | 82 | 2018 |
| Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between: MYB: Fusion and Protein Expression B Xu, E Drill, A Ho, A Ho, L Dunn, CN Prieto-Granada, T Chan, I Ganly, ... The American journal of surgical pathology 41 (10), 1422-1432, 2017 | 78 | 2017 |
| Incidence and mortality risk spectrum across aggressive variants of papillary thyroid carcinoma AS Ho, M Luu, L Barrios, I Chen, M Melany, N Ali, C Patio, Y Chen, ... JAMA oncology 6 (5), 706-713, 2020 | 76 | 2020 |
| DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation L Sun, L Huang, P Nguyen, KS Bisht, G Bar-Sela, AS Ho, CM Bradbury, ... Cancer research 68 (8), 2726-2735, 2008 | 64 | 2008 |
Zachary ZumstegCedars-Sinai Medical CenterDirección de correo verificada de cshs.org
